ETFs to Play the Reopening Trade on Merck's Oral Antiviral Pill NewsZacks Investment Research • 10/04/21
Merck's Molnupiravir: If Peer Reviews Confirm Results, The Implications Would Be MassiveSeeking Alpha • 10/04/21
What Merck's antiviral pill could mean for vaccine hesitancy — ‘It's not a magic pill'Market Watch • 10/01/21
Fauci says FDA will review Merck's new Covid treatment 'as quickly as they possibly can'CNBC • 10/01/21
US stocks close higher on Merck's new COVID-19 oral treatment announcementProactive Investors • 10/01/21